A real-world study has found that high percentages of patients with primary antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE)-related APS have poorly controlled cardiovascular (CV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback